24. Biofilm removal with the Perioflow
Enhanced OH combined with efficient removal
of Biofilm are the mainstay of implant
maintenance.
• Erythrotol - combined antibacterial and physical actions
• Flexible delivery ‘nozzle’ very effective around challenging
implant anatomy
• Used in ‘closed’ and open debridement
• Combined with targeted antibiotic therapy
25.
26.
27.
28. Special treatment planning
considerations for the elderly patient
• Reduced ‘neuroplasticity’
• Declining dexterity / impaired vision
• Complex medical history
• Treatment solutions ‘adapted’ or modified to take
these changes into consideration
• Work with current prosthesis rather than renew
33. • Success rates for endodontic therapy in
differing anatomical situations and with
differing presenting pathology.
• Success rates for implant therapy in differing
anatomical situations and the relevance of risk
factors for implant failure.
• A complex decision process?
34. How successful is modern endo?
• Primary Endo on vital tooth?
• On chronically infected teeth?
• Re – treatment?
• Apicectomy?
35. How successful are dental implants?
• Generally quoted ‘success’ rates actually
indicate survival.
• Effect of known risk factors for failure
‘unquantifiable’.
• Anatomical variations.
• GP or ‘Specialist’ practitioner?
36.
37.
38.
39.
40.
41.
42.
43.
44. With so many variables how can
we reliably advise our patients?
From our discussion, can we distil
some ‘golden rules’ or guidelines to
take away?
45. What do you think of these for starters?
• If a non vital tooth is restorable and
periodontally viable, endo is 1st option.
• Re-endo should always be first consideration
for a failing endo? But cost implications more
relevant?
• Implant therapy is more predictable than
apicectomy.